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During the course of studies on oxidation and reduction by pneumo- 
coccus made by Avery and Neill (1), Neill made the observation that 
when pneumococcus extract was injected into white mice hemorrhagic 
purpura developed.  At a later date, we made a  similar observation. 
This  paper is a report of the study of the nature of this phenomenon. 
In 1907,  Heyrovsky (2)  reported that he was able to produce pur- 
pura in white mice by injecting 24 hour filtrates of virulent pneumo- 
cocci grown in dextrose broth.  No other reference to  this  reaction 
has come to our attention. 
We have found that if pneumococcus extracts, prepared by one of 
the  various  methods  to  be described later,  are  injected  into white 
mice, after 4  to  6  hours  the skin over the feet, tail, ears, snout, and 
genitalia take on a dark bluish purple color.  This peculiar appearance 
is confined to the areas where the hair is either absent or scanty, but 
removal of the hair does not render the skin in the shaved area reactive. 
The intensity of the discoloration varies in the different regions and 
only one or several or all  of the  sites mentioned  may be involved. 
Unless the amount of extract injected is very large the animals show no 
signs of intoxication and all  recover.  The lesion  is  at its maximum 
intensity usually in 24 to 48 hours  following the injection and then 
slowly disappears, vanishing entirely in 5 to 7 days. 
The development of the reaction may best be observed in the ear by 
transmitted light.  It is then seen that  the lesion begins as a  small 
hemorrhage about the blood vessels and the extravasation extends into 
the surrounding tissues. 
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The microscopical changes  1 are best studied in sections made of the 
skin  and  viscera of animals  autopsied immediately  after  they have 
died or been killed by chloroform vapor.  It is then found that the 
changes are not confined to the skin but are also present in the lungs 
and  voluntary muscles.  The  essential  lesion  consists  of extravasa- 
tions of blood into  the  loose tissues surrounding  the  blood vessels. 
In the skin the hemorrhages  are usually found in the subcutaneous 
tissues, but may also be present in the superficial layers of the corium. 
The hemorrhages may be minute or may involve quite extensive areas. 
Frequently  small  collections  of  polymorphonuclear  leucocytes  are 
present in the hemorrhagic areas. 
The  degree of purpura  is influenced both by  the  amount  of  the 
material  introduced  and  the  individual  susceptibility of the  experi- 
mental animal.  Using a fixed quantity of extract for a series of mice 
there is considerable variation in the severity of the reaction in the 
individual  animals.  0.2  cc.  of extract  usually produces purpura  in 
half of the mice of a series.  0.4 cc. gives 90 per cent or more positive 
results with rather severe reactions.  More than this amount proves 
too toxic and  death  usually occurs,  although  some mice have been 
able to withstand 0.6 cc. and, rarely, 0.8 cc. of the extract. 
The reaction is produced equally well whether the extract is intro- 
duced subcutaneously, intraperitoneally, or intravenously.  The intra- 
venous method usually results in a more rapid  reaction.  Attempts to 
effect purpura by feeding have not, however, been successful.  After 
being subjected to chloroform, mice were fed by stomach tube with 
amounts much greater than necessary to cause purpura if injected, but 
in these cases no purpura was evidenced.  This is not surprising since 
trypsin destroys the activity of the purpura-producing principle. 
Purpura  was produced in  guinea pigs  and  rabbits  also.  In  the 
guinea pig the ears and the pads of  the feet were affected; while the 
ears  and  scrotum  of male  rabbits,--which  alone  were  used,--were 
chiefly involved. 
Derivatives of Pneumococcus Causing Purpura. 
In  our  study  the  development  of purpura  was  first  observed in 
white mice as a  response to injections of pneumococcus extract pre- 
1 The pathology of the effect of pneumococcus extract in experimental animals 
is under study by Dr. Branch and a report upon it will be made subsequently. LOUIS  A.  J-ULIANELLE  AND  HOBART  A.  REI~ANN  89 
pared according to the method of Avery and Neill (3).  Purpura was 
also produced inwhite mice byHeyrovsky's  method.  Cultures of pneu- 
mococcus  were grown in dextrose broth and a 1 day's growth was filtered 
and  injected  intraperitoneally.  The  reaction, however, was  much 
less constant and less severe than that obtained by the introduction of 
extract.  Moreover, when purpura did appear, as much as 1.5 to 2.0 
cc. were required to produce the reaction.  Filtrates of young cul- 
tures (8 to 16 hours) grown in plain beef infusion broth, however, have 
never yielded purpuric lesions.  Filtrates from very old cultures grown 
in plain infusion broth for 3 weeks only rarely have given purpuric 
reactions and when they did the activity was slight. 
Whole  cultures,  unfiltered,  rarely  cause  the  purpuric  reaction. 
Young cultures usually cause an infection followed by rapid death of 
the mice.  In hundreds of mice injected with young cultures of pneu- 
mococcus for one purpose or another never but once has purpura fol- 
lowed the injection.  On this occasion the mouse had been injected 
with  a  virulent  culture  together with  sufficient immune serum  to 
afford passive  protection.  On  the 5th  day following the injection 
purpura was noted.  It increased in intensity until the 7th day and 
then began to blanch.  The infection itself, however, does not prevent 
the appearance of purpura, for purpura results when an active extract 
is injected into an animal together with a minimum infecting dose of 
culture. 
Old cultures occasionally produce purpura.  Two strains of Type 
III have given the most consistent results.  After the original 24 hour 
culture in blood broth had been stored for a week or more in the ice 
chest, these strains were able to produce purpuric changes.  Since the 
mice were not severely infected, it is probable that during storage the 
cultures had undergone sufficient autolysis to be partially transformed 
into extract-like substances. 
Bile-dissolved cultures have never  induced  purpura,  even  when 
solutions prepared from young cultures of pneumococci, concentrated 
to the same extent as is done in preparing extracts, and dissolved in a 
minimum quantity of bile,  are employed.  That bile in  itself does 
not inhibit the purpurogenic activity of an extract was shown by add- 
ing bile to an active extract in a concentration of 10 per cent.  This 
mixture injected into mice produced purpura. 90  PRODUCTION  OF  PURPURA.  I 
Pneumococci which  had been killed by exposure to a  temperature 
of 56°C.  for 30 minutes,--a treatment sufficient to kill  the  pneumo- 
cocci  but  not  to  destroy  the  activity  of  the  purpura-producing 
material,--did  not  produce  purpura  in  white  mice.  The  soluble 
specific substance and  nucleoprotein  of  pneumococcus (Heidelberger 
and Avery (4))  failed to produce  purpura  regardless  of  the quantity 
injected. 
The observations so far recorded suggest that the  substance, which 
on injection  gives rise  to purpura,  is  contained  in  the  bodies  of  the 
pneumococci  and  is  set  free  by  the process of  extraction  employed. 
It  is  also  found  occasionally in  the  culture filtrate.  It has been of 
importance to determine whether  this  substance  exists preformed in 
the bacterial cell  or whether  it  is  a  product  of  a  digestive  process 
occurring during the process of extraction. 
Concentrated  suspensions  of  pneumococci  were  prepared  by  centrifuging 
1500 cc. of a 9 hour broth culture and suspending  the sediment in 15 cc. of broth. 
When  trypsin  was  allowed  to act on a  portion of this concentrated suspension 
the resulting fluid was not  active.  This was the case whether the bacteria in the 
emulsion  were alive or had been killed  by heat before exposure to the action of 
trypsin. 
If, instead of trypsin, the native enzymes of the pneumococcus were allowed 
to act on the concentrated emulsion,  the results were quite different, since the 
product in this case was highly active.  In this experiment to 15 cc. of the concen- 
trated pneumococcus emulsion, 10 cc. of an homologous extract containing the 
pneumococcus enzymes (Avery and Cullen (5)) were added and the mixture was 
incubated  for 40  hours  at  37°C.  The  mixture was  then  centrifuged  and  the 
supernatant fluid  filtered.  This filtrate was  now found to be as active as the 
pneumococcus extract prepared by the Avery-Neill method. 
The Nature of the Purpura-Producing Prit~eiple. 
Aliquot portions of pneumococcus extract were heated at 60°C.,  70°C., 80°C., 
and 100°C. for 10 minutes each.  At the higher temperature exposures,  coagula- 
tion occurred.  The various specimens were injected individually into the peri- 
toneum of white mice and it  was observed that  heating even at  100°C. for  10 
minutes did not  destroy the  activity of the purpura-producing material.  The 
results are appended in Table I. 
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interest to determine, therefore, the effect of oxidation on the purpura- 
producing  principle  of  the  extracts.  Pneumococcus  extract  was 
oxidized until it was  no  longer  hemolytic.  It was  still  capable  of 
producing purpura when injected into white mice.  It can be  said, 
then, that the purpura-producing principle is not associated with the 
hemolytic activity of the extracts, since the latter alone is destroyed 
by heat and oxidation. 
Extracts of all groups of pneumococci contain the purpura-produc- 
ing  material.  Experiments  performed  to  correlate  the  purpura- 
producing  activity with  virulence  showed  no  relationship  between 
these  two  properties.  An  avirulent  Group IV strain gave as good 
a  purpura-producing  extract  as  any  of  the  most  highly  virulent 
strains in this laboratory. 
TABLE  I. 
The Effect of Heat on the Purpura-Producing Material. 
Each mouse was injected intraperitoneally wth 0.4 cc. of the respective extract. 
No. of mice 
No. of mice  developing  Type of extract,  in test. 
purpura. 
Unheated  extract ..................................... 
Extract  heated  10  rain. at  60°C ........................ 
"  "  10  "  "  70 °''  ...................... 
"  "  10  "  "  80 °''  ...................... 
"  "  10  "  "  100 °  "  ...................... 
Because it has been shown (6, 7) that an avirulent culture  of pneu- 
mococcus may be  a  strain composed of both virulent and avirulent 
organisms,  the  experiment was  extended  to  include  a  study of  the 
extracts prepared from  the  R  or  purely  avirulent strains.  It  was 
shown that the extracts possessed purpura-producing material. 
Isolation of the Purpura-Producing Material. 
For the isolation of the purpura-producing material from the extracts, saline ex- 
tracts of pneumococcus were prepared  according to the technique of Avery and 
Neill.  These extracts were equivalent to the broth extracts in producing purpura. 
Normal acetic acid was added slowly to the saline extract until no further precip- 
itation occurred.  The material was centrifuged and all of the supernatant was 
withdrawn.  The sediment was washed with normal salt solution, then dissolved 
in weak alkali and neutralized,  and the volume was adjusted to the original 92  PRODUCTION  OF PURPURA.  I 
quantity.  The supernatant no longer  gave a precipitate with acetic acid.  It was 
neutralized with normal NaOH. 
The supernatant was next half saturated with (NH4)2S04 and a precipitate 
was obtained.  This was centrifuged and the supernatant was collected  and made 
up to full saturation with  (NH4)2SO4 and another precipitation was obtained. 
The acetic acid precipitate, which contained essentially the nucleo- 
proteins of pneumococcus (4)  produced  no  purpuric  lesions  when 
injected into white mice.  This was in accordance with the earlier 
observation  on  the  nucleoprotein fraction.  The  supernatant  from 
the acetic acid precipitation, on the other hand, was still able to pro- 
duce purpura with apparently no loss in this property.  The precipi- 
tate obtained by half saturation with (NH4)~SO4 did not contain the 
purpura material while the supernatant was still purpura-producing. 
The precipitato obtained by full saturation with (NH4) 2SO4 was shown 
to  contain  the  purpura-producing  principle.  This  precipitate  was 
washed free of salts by dialysis. 
It was found that the purified purpura-producing principle was co- 
agulated on heating and was precipitated by trichloracetic acid, sulfo- 
salicylic acid, and  alcohol.  It  gave  a positive biuret reaction, but 
did not give a xanthoproteic reaction and the Millon reaction was a 
doubtful  one.  The  activity to  cause  purpura  was  destroyed  by 
trypsin digestion. 
The purified material acted like the extracts themselves and mice 
showed the same degree of variation in susceptibility to it that they 
did to the extracts.  As small an amount as 0.04 mg.,L-a dosage of 
about  1/500,000  of  the  body  weight,--was  sufficient  to  produce 
purpura in some of the mice.  It proved to be highly toxic for rabbits, 
and 0.16  to 3.2 rag. was fatal to 3 rabbits.  The purpura-producing 
substance was not precipitated either by anti-extract or antipneumo- 
coccus sara. 
Purpuric Responses to Extracts from Other Bacteria. 
Experiments were conducted to determine whether the purpura- 
producing material was peculiar to pneumococcus alone.  Extracts 
These quantities were calculated as protein on the basis of the organic  nitrogen 
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were made of two  strains  of Staphylococcus  aureus,  three strains  of 
Streptococcus viridans,  one strain of hemolytic streptococcus, and one 
strain of Bacillus coli. 
For these organisms 3 the preparation of the  extracts was modified, since rapid 
freezing and thawing did not give solutions of the bacterial cells.  The cultures 
were centrifuged and to the sediment was added a small amount of sterile sand. 
The bacteria were then dried in vacuo at a temperature not exceeding 37°C. and 
then ground in a ball mill at room temperature for varying periods of 48 hours or 
mor~ until a fine powder was obtained.  At this  stage N/100 alkali  was added 
and extraction was allowed to take place in the ice chest, in the ball mill.  On the 
following day the material was removed and centrifuged and the supernatant was 
used in the experiments.  Care was taken to keep the concentrations equivalent 
to that of the pneumococcus extract. 
Extracts  were  prepared  from  four  strains  of  meningococcus  by 
freezing and thawing. 
The extracts from these organisms were not capable of producing 
purpura in white mice.  Amounts  as  great as  2.5  cc. were used for 
injection. 
DISCUSSION. 
Evidence has  already been presented to show that pneumococcus 
extracts  possess  a  powerful  hemolysin  and  an  oxldation-reduction 
system which is  operative on hemoglobin  (Avery and  Neill).  The 
present paper offers data to show that the extracts possess in addition 
a toxic principle whichis capable of producing experimental purpura in 
animals.  This activity is derived from extracts of avirulent as well 
as  of virulent pneumococci.  Extracts  of the  other  bacteria  tested 
either do not possess this activity, or the methods which were applic- 
able for pneumococcus were inadequate to demonstrate it. 
The purpura-producing material is obtained from the extracts by 
full saturation  with  (NH4)~SO4.  Whether it is an  albumin  or some 
closely related substance as a higher proteose, for example, for which 
albumin  may  act  merely  as  a  vehicle  remains  to  be  determined. 
It is significant that bile solutions of pneumococci did not yield the 
purpura-producing  substance.  That,  on the  other  hand,  bile  does 
not prevent its activity has  also been shown.  And those  constitu- 
8We are indebted to R. C. Lancefield for this method. 94  PRODUCTION  OF  PURPURA.  I 
ents of the pneumococcus which exist preformed in the cell are recover- 
able by dissolution of the cell with bile.  The method has been used 
successfully by Cole (8)  to obtain the hemolysin, and by Avery and 
Cullen  (9)  to  obtain the enzymes of pneumococcus.  The purpuric 
substance was found to be present in  those  materials alone  which 
represented degradation products of pneumococci.  It appears prob- 
able, therefore, that the purpura-producing property is due not to  a 
constituent of the living pneumococcus  cell,  but  to  a  degradation 
product of pneumococcus.  That it is a separate entity from the pneu- 
mococcus hemotoxin has been shown  selectively.  The  hemotoxin 
can be eliminated by oxidation and heat, while neither of these means 
destroys the activity of the purpura-producing material.  Autolysates 
of pneumococcus are definitely purpura-producing, yet, as  prepared 
by our method, they contain no demonstrable hemotoxin.  The fact 
that autolysates  were  purpura-producing  while  autolyzed  cultures 
were rarely, and at best, poorly purpura-producing, is explainable on 
the basis of concentration, since the autolysates were 50 times more 
concentrated than the cultures. 
It is well recognized that  purpura  accompanying pneumococcus 
infections in man is of extreme rarity.  There are, however, occasional 
instances recorded in the literature.  Bazan (10)  and Nob6court and 
Mathieu (11)  have reported upon them.  In their cases the purpura 
always preceded death.  Whether there is any relation between the 
purpura-producing principle and the pneumococcus infections cannot 
be said at  the present time.  It is  quite  possible  that the purpura 
substance may function in infections without necessarily producing 
visible  signs  of  purpura.  Experiments  are  planned  to  determine 
whether  the  purpura  principle  plays  any  part  in  pneumococcus 
infections. 
CONCLUSIONS. 
1.  Pneumococcus extracts have been shown to be capable of pro- 
ducing hemorrhagic purpura in white mice, rabbits, and guinea pigs. 
2.  The purpura-producing principle resists heating to 100°C.  for 10 
minutes; it resists oxidation; it is filter-passing; its activity is destroyed 
by digestion with trypsin; it is obtained from pneumococcus extracts 
by full saturation with (NH4)2SO4, after the acetic acid-precipitable 
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3.  The purpura-producing principle is common to all  four types of 
pneumococcus and apparently bears no relation to virulence. 
4.  The  purpura-producing  principle  is  probably  a  degradation 
product of pneumococcus. 
5.  This principle is not associated with the hemotoxin of pneumo- 
coccus, since the hemolytic activity of an extract may be destroyed 
without effect on the ability to  cause purpura. 
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